MARSHALL & POPP, LLC

Lobbying for BRIDGEBIO PHARMA · Biopharmaceutical manufacturer.

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · California · House · Senate · $60,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Pharmacy

Issues related to pharmaceutical manufacturing, drug pricing, and orphan drugs.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem